APPLICATION
NDA012516
TYPE
NDA
ORIGINAL APPROVAL
1962-02-12
LATEST ACTION
2001-12-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
SANSERTDiscontinued
METHYSERGIDE MALEATE 2MG · TABLET · ORAL
Approval history
2001-12-03Manufacturing (CMC) · Supplement 50 · priorityAP
2001-05-10Manufacturing (CMC) · Supplement 49 · priorityAP
2000-12-11Labeling · Supplement 45 · priorityAP
2000-12-11Labeling · Supplement 41 · priorityAP
2000-12-11Labeling · Supplement 38 · priorityAP
2000-03-16Manufacturing (CMC) · Supplement 48 · priorityAP
1999-10-15Labeling · Supplement 46 · priorityAP
1999-10-15Labeling · Supplement 40 · priorityAP
1999-04-21Manufacturing (CMC) · Supplement 47 · priorityAP
1996-03-20Manufacturing (CMC) · Supplement 44 · priorityAP
1995-11-22Manufacturing (CMC) · Supplement 43 · priorityAP
1995-10-17Manufacturing (CMC) · Supplement 42 · priorityAP
1981-08-10Manufacturing (CMC) · Supplement 25 · priorityAP
1981-08-10Manufacturing (CMC) · Supplement 26 · priorityAP
1978-10-11Manufacturing (CMC) · Supplement 24 · priorityAP
1978-03-20Manufacturing (CMC) · Supplement 22 · priorityAP
1976-05-07Manufacturing (CMC) · Supplement 21 · priorityAP
1976-01-29Manufacturing (CMC) · Supplement 19 · priorityAP
1975-08-12Manufacturing (CMC) · Supplement 18 · priorityAP
1975-01-06Manufacturing (CMC) · Supplement 17 · priorityAP
1974-08-26Labeling · Supplement 16 · priorityAP
1974-07-03Manufacturing (CMC) · Supplement 15 · priorityAP
1962-02-12Type 1 - New Molecular Entity · Original · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.